New Research: Antithrombotic use shown to improve COVID-19

New research published today from the BHF Data Science Centre’s CVD-COVID-UK Consortium suggests the use of blood-thinning medications in patients with cardiovascular disease is associated with lower risk of death from COVID-19. 

IHI’s Alex Handy, the lead researcher of the study, said “We observed that people already taking antithrombotics were marginally less likely to die from COVID-19, but were also marginally more likely to be hospitalised. We saw the same pattern in people taking other blood thinning drugs called anticoagulants. 

“This pattern could be a result of people taking this kind of medication being more likely to access healthcare, but it may also mean that antithrombotics only help in the most serious cases of COVID-19.  

Read the full paper

Credits to HDR UK Comms Team.